About US
Contact us
-
"Noble" an Aptar Pharma Company Launches Human Factors Engineering Services2021/3/3
-
3-shot combo? Pfizer, BioNTech roll COVID-19 booster trial as real-world data back first vaccineAs Pfizer and BioNTech start testing whether a third dose of their COVID-19 shot can help fend off new coronavirus variants, a massive real-world study has confirmed that its first, two-dose regimen2021/3/1
-
Lilly scores $210M supply deal for newly authorized coronavirus antibody cocktailAs U.S. officials look to ramp up COVID-19 vaccinations heading into March, they’re not overlooking another pandemic-fighting tool. Eli Lilly on Fridayscoreda government supply deal for its newly aut2021/3/1
-
Bristol Myers, hot off Breyanzi nod, plots new cell therapy factory in MassachusettsBristol Myers Squibb, freshly armed with an approval for its CAR-T lymphoma therapy Breyanzi, is making a major cell therapy manufacturing play. The company isbuilding outa new244,000-square-foot cel2021/2/25
-
Catalent continues cell and gene therapy push with deal for Belgian CDMOCatalent's Belgian manufacturing foothold is widening, as the company moves to acquire yet another cell and gene therapy CDMO in the area. Catalent locked in a deal tobuy 100% of the shares of2021/2/25
-
AbbVie, Eli Lilly lead Big Pharma's 2020 market cap growth as Merck, Gilead lagCOVID-19 products aren’t guarantees of market cap growth at biopharma companies these days—and a lack of them doesn’t deprive a drugmaker, either—if a year-end comparison between 2020 and 2019 is a2021/2/23
-
After Pfizer deal, Sanofi offers a hand to Johnson & Johnson for COVID-19 vaccine productionSanofi hasn't abandoned its COVID-19 vaccine hopes despite a setback in the high-stakes race, but as it moves two different shots forward, it's also pitching in to make doses for its usualrivals. The2021/2/23
-
Charles River jumps into cell and gene therapy manufacturing with $875M Cognate buyJust a few weeks after Cognate BioServices moved to beef up its cell and gene therapy manufacturing, the company has attracted a buyer eager to tap that expertise. Charles River Laboratories agreed t2021/2/19
-
Inspectors force AstraZeneca's Mexico vaccine partner to overhaul its factory, holding up shot productionWhile Mexico is receiving small shipments of AstraZeneca's COVID-19 vaccines from overseas, two large shipments of the active ingredient used to make it remain unused. The holdup? Problems at a domes2021/2/19
-
AstraZeneca, Oxford race to update COVID-19 vaccine as study flags weak action against variantIt didn’t take long before a morale boost forAstraZeneca’s COVID-19 vaccine was overshadowed by disappointment over itswaned protection against a newly emerged coronavirus variant. A new study has fo2021/2/9